Subsai Kongsaengdao
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Apr 25, 2025
A 12-Week Prospective, Double-Blind, Multicenter, Randomized Study Comparing 100 Units of Abobotulinum Toxin Type A (Dysport®) and 33.33 Units of Neubotulinum Toxin Type A (Neuronox®) for the Treatment of Hemifacial Spasm.Subsai Kongsaengdao, Arkhom Arayawichanont, Kanoksri Samintharapanya
|Oct 22, 2021
Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.Subsai Kongsaengdao, Arkhom Arayawithchanont, Kanoksri Samintharapanya
|Apr 03, 2021
The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A.Subsai Kongsaengdao, Narong Maneeton, Benchalak Maneeton
Pageof 1